Selim Corbacioglu, MD, PhD - Transforming Transfusion Dependence: Practical Steps for Incorporating Novel Beta Thalassemia Treatments Into Practice

episode

CME in Minutes: Education in Oncology & Hematology not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

NPR News: 09-19-2026 1PM EDT 4 min · 19 Sep 2026 · NPR News Now

OPENLINE | SATURDAY 19TH SEPTEMBER 43 min · 19 Sep 2026 · Superscoreboard

NPR News: 09-19-2026 12PM EDT 4 min · 19 Sep 2026 · NPR News Now

What European Politicians & Immigrants Say Behind Closed Doors | Dominik Tarczyński 52 min · 19 Sep 2026 · The Rubin Report

The Scott Brown Interview That Changed The Story 20 min · 19 Sep 2026 · Morning Wire

Best of the Week on The Dan Patrick Show 59 min · 19 Sep 2026 · The Dan Patrick Show

Report any issue

Source

Recorded04 Jul 2025

Publisherc.answersincme.com ↗

Handlerec:765987

Show notes

Please visit answersincme.com/BUS860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in hematology discusses the latest treatments for transfusion-dependent beta thalassemia (TDT). Upon completion of this activity, participants should be better able to: Evaluate the clinical implications of the efficacy and safety data for novel TDT therapies; Identify appropriate patients for novel TDT therapies; and Apply strategies to integrate novel TDT therapies into real-world clinical practice.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in